| Last Price |
Change |
Volume |
|
|
|
|
|
| Open: |
Day Range: |
Prev Close: |
Quarterly rpt on consolidated results for the financial period ended 30 Sep 2022
| Financial Year End |
31 Dec 2022 |
| Quarter |
3 Qtr |
| Quarterly report
for the financial period ended |
30 Sep 2022 |
| The figures |
have not been audited
|
Currency: Malaysian Ringgit (MYR)
| |
INDIVIDUAL PERIOD
|
CUMULATIVE PERIOD
|
CURRENT YEAR QUARTER
|
PRECEDING YEAR
CORRESPONDING
QUARTER
|
CURRENT YEAR TO DATE
|
PRECEDING YEAR
CORRESPONDING
PERIOD
|
|
30 Sep 2022
|
30 Sep 2021
|
30 Sep 2022
|
30 Sep 2021
|
|
|
$$'000
|
$$'000
|
$$'000
|
$$'000
|
|
1
|
Revenue
|
23,893
|
17,445
|
80,067
|
61,449
|
| 2 |
Profit/(loss) before tax |
1,709
|
520
|
5,711
|
1,635
|
| 3 |
Profit/(loss) for the period |
1,020
|
158
|
3,465
|
808
|
| 4 |
Profit/(loss) attributable to ordinary equity holders of the parent
|
951
|
71
|
2,495
|
31
|
| 5 |
Basic earnings/(loss) per share (Subunit)
|
0.14
|
0.01
|
0.36
|
0.01
|
| 6 |
Proposed/Declared dividend per share (Subunit)
|
0.00
|
0.00
|
0.00
|
0.00
|
|
|
AS AT END OF CURRENT QUARTER
|
AS AT PRECEDING FINANCIAL YEAR END
|
7
|
Net assets per share attributable to ordinary equity holders of the parent ($$)
|
0.1700
|
0.1700
|
Currency:
| |
INDIVIDUAL PERIOD
|
CUMULATIVE PERIOD
|
CURRENT YEAR QUARTER
|
PRECEDING YEAR
CORRESPONDING
QUARTER
|
CURRENT YEAR TO DATE
|
PRECEDING YEAR
CORRESPONDING
PERIOD
|
|
|
|
|
|
|
|
$$'000
|
$$'000
|
$$'000
|
$$'000
|
| 1 |
Revenue
|
|
|
|
|
| 2 |
Profit/(loss) before tax |
|
|
|
|
| 3 |
Profit/(loss) for the period
|
|
|
|
|
| 4 |
Profit/(loss) attributable to ordinary equity holders of the parent |
|
|
|
|
| 5 |
Basic earnings/(loss) per share (Subunit)
|
|
|
|
|
| 6 |
Proposed/Declared dividend per share (Subunit)
|
|
|
|
|
|
|
AS AT END OF CURRENT QUARTER
|
AS AT PRECEDING FINANCIAL YEAR END
|
7
|
Net assets per share attributable to ordinary equity holders of the parent ($$)
|
|
|
Announcement Info
| Company Name |
SUNZEN BIOTECH BERHAD
|
| Stock Name |
SUNZEN |
| Date Announced |
29 Nov 2022 |
| Category |
Financial Results |
| Reference Number |
FRA-23112022-00101 |
|
|